Abstract aA-and aB-crystallins are distinct antiapoptotic regulators. Regarding the antiapoptotic mechanisms, we have recently demonstrated that aB-crystallin interacts with the procaspase-3 and partially processed procaspase-3 to repress caspase-3 activation. Here, we demonstrate that human aA-and aBcrystallins prevent staurosporine-induced apoptosis through interactions with members of the Bcl-2 family. Using GST pulldown assays and coimmunoprecipitations, we demonstrated that a-crystallins bind to Bax and Bcl-X S both in vitro and in vivo. Human aA-and aB-crystallins display similar affinity to both proapoptotic regulators, and so are true with their antiapoptotic ability tested in human lens epithelial cells, human retina pigment epithelial cells (ARPE-19) and rat embryonic myocardium cells (H9c2) under treatment of staurosporine, etoposide or sorbitol. Two prominent mutants, R116C in aA-crystallin and R120G, in aB-crystallin display much weaker affinity to Bax and Bcl-X S . Through the interaction, a-crystallins prevent the translocation of Bax and Bcl-X S from cytosol into mitochondria during staurosporine-induced apoptosis. As a result, a-crystallins preserve the integrity of mitochondria, restrict release of cytochrome c, repress activation of caspase-3 and block degradation of PARP. Thus, our results demonstrate a novel antiapoptotic mechanism for a-crystallins. Keywords: aA-crystallin; R116C; aB-crystallin; R120G; Bax; Bcl-X S Abbreviations: a-crystallin, alpha-crystallin; GFP, green fluorescence protein; HaA, human aA-crystallin; HaB, human aB-crystallin; GFP-HaA, green fluorescence and human aAcrystallin fusion protein; GFP-HaB, green fluorescence and human aB-crystallin fusion protein; MEM, Eagle's minimal essential medium; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; PMSF, phenylmethylsufonyl fluoride; HLE, human lens epithelial cells; SDS, sodium dodecylsulfate; TBS, tris-buffered saline; TBS-T, tris-buffered saline with tween-20.
Introduction
Apoptosis is one of the major causes for ocular diseases. [1] [2] [3] In lens system, our previous work [4] [5] [6] has suggested that induced lens epithelial cell apoptosis appears to be a common cellular mechanism mediating stress-induced, noncongenital cataractogenesis. Subsequently, several laboratories have reported that lens epithelial cell apoptosis is indeed actively involved in lens pathogenesis as demonstrated from in vivo animal model studies. [7] [8] [9] [10] [11] [12] In addition, both overexpression of various exogenous genes and disruption of certain endogenous genes also lead to lens cell apoptosis followed by abnormal lens formation during lens development. [13] [14] [15] [16] [17] [18] Apoptosis is regulated by a series of positive and negative regulators. The balance of these regulators controls the determination of apoptosis. Among these various apoptotic regulators, members of Bcl-2 family and heat-shock proteins play an important role. [19] [20] [21] So far, members of the Bcl-2 family are the most wellcharacterized apoptotic regulators and are generally classified into two functional groups. 21 Members of the first group, including Bcl-2 and Bcl-X L , possess antiapoptotic ability, while members of the second group such as Bak, Bax and Bcl-X S have been shown to promote apoptosis. 21 The functions of Bcl-2 family members could be regulated by their subcellular localization. Bcl-2 and Bcl-X L are localized on the mitochondrial membrane, endoplasmic reticulum (ER) and nuclear membrane. 21, 22 In contrast, a substantial fraction of Bax is found in the cytosol and loosely attached to the mitochondrial membrane prior to induction of cell death. 23 In the absence of death stimuli, the N-terminus of Bax helps to maintain the inactive status of Bax by restraining the C-terminal transmembrane (TM) domain in the cytosol. 24 Lack of the N-terminus of Bax or replacement of the TM domain of Bax with the corresponding domain of Bcl-2 permits the integration of Bax into the mitochondrial membrane. 25 The C-terminal TM domain of Bax is critical for its targeting to mitochondrial membrane. Deletion and point mutations of the C-terminal hydrophobic region severely damage the ability of Bax to integrate into the mitochondrial membrane and kill cells.
of Bax changes its conformation and the C-terminal a-helix is removed from the BH3 domain, which allows the BH3 domain to interact with other antiapoptotic Bcl-2 family members. 27, 28 Caspase 25 and p38 MAP kinase 29 may stimulate the translocation of Bax upon apoptotic stimulus. After Bax inserts into the mitochondrial membrane, Bax can directly induce the release of cytochrome c 30, 31 or form permeability transition pore. 32 Bcl-X S is a proapoptotic regulator with only the BH3, BH4 and TM domains. 33 Several reports have demonstrated that overexpression of Bcl-X S selectively induces tumor cells to undergo apoptosis. [34] [35] Moreover, overexpression of Bcl-X S in the skin of transgenic mice results in extreme sensitivity to UV-induced cell death. 36 Bcl-X S has been suggested to stimulate apoptosis through inactivation of antiapoptotic Bcl-2 family members, such as Bcl-2 and Bcl-X L , 33 or repression of the binding of Bcl-X L to cytochrome c. 37 The endogenous Bcl-X S is distributed in the cytosol, but is translocated to the mitochondrial membrane upon overexpression. Its proapoptotic ability can be inhibited by Bcl-2 and Bcl-X L . 38 Another important group of apoptosis regulators are heatshock proteins that include alpha-crystallins (a-crystallins), [39] [40] [41] [42] [43] [44] [45] [46] Hsp27, [39] [40] [47] [48] [49] [50] [51] [52] Hsp70, [53] [54] [55] [56] [57] Hsp90 58 and Hsp60. [59] [60] While Hsp60 appears to enhance apoptosis by promoting maturation of procaspase-3, 59 ,60 the majority of these factors seems to protect cells from induced apoptosis through different mechanisms. Hsp90 is able to inhibit apoptosome formation. 58 Hsp70 can interact with BAG-1 57, 58 and inhibit apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome complex. 53 Hsp70 is also capable of functioning downstream of caspase activation. 54 Hsp27 prevents cell death at multiple signaling steps. First, it interacts with cytochrome c to prevent activation of procaspase-9. 47, 48 It also binds to caspase-3 and modulates the activity of caspase-3. 49 Finally, Hsp27 can abrogate apoptotic pathway through regulation of Bid intracellular distribution and protection of F-actin integrity. 52 Both a-crystallins and Hsp27 are closely related family members. [19] [20] 61 aA/B-crystallins are initially known as major lens structural proteins that play an essential role in maintaining the transparency of the ocular lens. 62 Later, a-crystallins are found to act as molecular chaperones [63] [64] [65] [66] [67] and also display autokinase activity. 68, 69 As antiapoptotic regulators, acrystallins are initially shown to protect cells from thermal, 70 osmotic 71 and oxidative insult. 72 More recently, a-crystallins have been shown to prevent induced apoptosis by various factors including staurosporine, [39] [40] 43 TNF, 39, 43 UVA irradiation, 43 okadaic acid 44 and hydrogen peroxide. 45 Regarding the antiapoptotic mechanism, recent studies from our laboratory and another group have demonstrated that aBcrystallin can directly interact with the precursors of caspase-3 to suppress its activation. 45, 46 In the present study, we have explored the interactions between a-crystallins and members of the Bcl-2 family. Our results demonstrated that human aA-and aB-crystallins (HaA and HaB) can directly bind to Bax and Bcl-X S in vitro and in vivo. The two crystallins display almost close affinity to both proapoptotic regulators, and so are true with their antiapoptotic ability tested in three different cell lines under treatment of different stress conditions. The two prominent mutants, R116C in aA-crystallin and R120G in aB-crystallin, displayed much weaker affinity to Bax and Bcl-X S . The two crystallins markedly sequestered Bax and Bcl-X S in the cytosol and prevented their translocation into mitochondria during staurosporine-induced apoptosis. In contrast, the two mutants only weakly sequestered Bax and Bcl-X S in the cytoplasm. As a result of this interaction, the two crystallins preserve the integrity of mitochondria and turn off the downstream apoptotic events. Thus, our results provide a novel antiapoptotic mechanism for aA/B-crystallins.
Results

Expression of human a-crystallins in human lens epithelial (HLE) cells
To study the mechanisms by which a-crystallins protect lens epithelial cells from stress-induced apoptosis, we cloned both aA-and aB-crystallin cDNAs from human eye lenses (National Disease Research Interchange). Then, we generated the in frame constructs expressing fusion proteins of HaA and HaB with green fluorescence protein (GFP). These expression constructs (pEGFP-HaA and pEGFP-HaB) and the vector (pEGFP-neo) were transfected into the HLE cells using electroporation. 44, 45 The stable expression clones of pEGFP-HLE (expressing only GFP from the vector), pEGFP-HaA-HLE (expressing GFP-HaA) and pEGFP-HaB-HLE (expressing GFP-HaB) were obtained after a 6-week selection with G418 (600 mg/ml). As shown in Figure 1 , expression of GFP, green fluorescence and human aAcrystallin fusion protein (GFP-HaA) and green fluorescence and human aB-crystallin fusion protein (GFP-HaB) can be detected by fluorescence microscopy. The GFP was distributed homogeneously throughout the nucleus and cytoplasm ( Figure 1a ). In contrast, the GFP-HaA (Figure 1b ) and GFP-HaB ( Figure 1c) were localized in the cytoplasm only. Western blot analysis was conducted to further confirm the expression of these proteins. As shown in Figure 1d (top panel), the anti-aA/B-crystallin antibody recognized the GFPHaA in pEGFP-HaA-HLE cells and GFP-HaB in pEGFP-HaB-HLE cells, respectively. Expression of the endogenous HaA or HaB was hardly detectable in all three types of cells (data not shown). When anti-GFP antibody was used to probe the same blot (the second panel from the top of Figure 1d ), the same GFP-HaA and GFP-HaB were detected in pEGFP-HaA-HLE and pEGFP-HaB-HLE cells, respectively. In pEGFP-HLE cells, however, anti-GFP antibody recognized only the 27 kDa GFP protein. As a control for equal loading, the anti-b-actin antibody was used to probe the same blot and the results are shown in the third panel from the top of Figure 1d . Thus, the three different cell lines, pEGPF-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE, were successfully established. To quantitate the expression of GFP, GFP-HaA and GFP-HaB in pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells, respectively, purified GFP protein of different concentrations was loaded into the same gel for comparison (bottom panel). After probing with anti-GFP antibody, it was determined that the clone of pEGFP-HLE cells contained about 0.5 ng GFP/mg total proteins, that the clone of pEGFP-HaA-HLE cells expressed about 0.48 ng GFP-HaA/mg total proteins and that the clone of pEGFP-HaB-HLE cells had about 0.42 ng GFPHaB/mg total proteins.
HaA-and HaB-crystallins prevent staurosporineinduced apoptosis in HLE cells
Our previous studies 44, 45 have demonstrated that mouse aBcrystallin can block okadaic acid and H 2 O 2 -induced apoptosis in the immortalized rabbit lens epithelial cells, N/N1003A. To delineate the antiapoptotic mechanisms of aA-and aBcrystallins, we utilized our established stable clones, pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE. After grown to 100% confluence, these cells were subjected to treatment with 100 nM staurosporine for 3, 6, 12 and 17 h. The percentage of apoptotic cells in these samples was analyzed with a viability assay described before. 44, 45 As shown in Figure 2a , after a 3 h treatment, about 30% vector-transfected cell underwent apoptosis. In contrast, less than 20% of either HaA-or HaB-transfected cells were apoptotic. A 6 h treatment led to apoptosis of more than 60% of the vector-transfected cells. However, less than 30% of pEGFP-HaA-HLE cells and 25% of pEGFP-HaB-HLE cells were found apoptotic under the same conditions. The apoptotic nature of cell death was verified by DNA fragmentation (Figure 2b ). After a 6 h treatment, the DNA from vector-transfected cells displayed a clear pattern of fragmentation (Lane 3 of Figure 2b ). However, the DNA samples from either HaA-or HaBtransfected cells displayed a much weak fragmentation (lanes 5 and 7 of Figure 2b ). Thus, HaA-and HaB provide marked protection against staurosporine-induced apoptosis. Viability assays. pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells were grown to 100% confluence, then treated with 100 nM staurosporine for 3, 6, 12 and 17 h. Viability of the three types of cells was determined as described previously. 99 (b) DNA fragmentation assay. pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells were grown to 100% confluence, then treated with 100 nM staurosporine or 0.01% DMSO (control) for 6 h. Then, the cells were harvested for isolation of genomic DNA and the isolated DNA samples were analyzed with 2.0% agarose gel as described previously. 4 The 123 bp marker from Gibco BRL was shown on the left. STS: staurosporine HaA-and HaB-crystallins prevent staurosporineinduced upregulation of Bak in human lens epithelial cells
As overexpression of a-crystallins significantly protected HLE cells from staurosporine-induced apoptosis, we first examined whether the antiapoptotic ability of a-crystallins was derived from their regulation of expression of Bcl-2 family members. The pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells were incubated with either 0.01% DMSO or 100 nM staurosporine for 3 h. The total proteins were extracted for Western blot analysis and the results are shown in Figure 3 . The relative expression levels of GFP-aA/B-crystallin fusion proteins, Bcl-2, Bcl-X L , Bcl-X S , Bax and Bak, were further quantitated using an automated digitizing system from the Silk Scientific Corporation. While expression of Bcl-2, Bcl-X L , Bcl-X S and Bax showed only slight variations in vector-and acrystallin-transfected cells with or without staurosporine treatment ( Figure 3 and data not shown), expression of Bak was upregulated about five-fold in vector-transfected cells by staurosporine treatment. In HaA-and HaB-transfected cells, expression of either HaA or HaB enhanced expression of Bak for about 2.5-fold. However, staurosporine-induced additional upregulation was not observed in HaA-and HaB-transfected cells. Thus, HaA and HaB were able to suppress staurosporine-induced upregulation of Bak in HLE cells.
HaA-and HaB-crystallins can interact with Bcl-X S and Bax in vitro and in vivo
To explore whether aA-and aB-crystallins are able to prevent apoptosis at the mitochondrial level, upstream of caspase-3 activation, as part of the antiapoptotic mechanism, we conducted GST pulldown assays to identify possible interactions between HaA-crystallin as well as HaB-crystallin with members of the Bcl-2 family. The cDNAs for HaA-and HaBcrystallins were subcloned into pGEX-4T-1 vector to establish (in frame) GST-HaA-and GST-HaB-crystallin fusion protein constructs. The purified GST-HaA-and GST-HaB-crystallin fusion proteins from Escerichia coli BL21 were used to pull down the HaA-and HaB-crystallins-associated proteins from HLE cells. The proteins pulled down were further analyzed with antibodies against various members of the Bcl-2 family. As shown in Figure 4 , both Bax (the third panel from top) and Bcl-X S (the fourth panel from the top) were found bound to GST-HaA-and GST-HaB-crystallins, but not to the GST protein control. In contrast, the anti-Bcl-2 and anti-Bak antibodies did not crossreact with any proteins eluted from either GST-HaA or GST-HaB columns (the top two panels of Figure 4 ). To confirm that the interaction actually occurs in vivo, coimmunoprecipitates from the pEGFP-HLE, pEGFPHaA-HLE and pEGFP-HaB-HLE cells using anti-aA/B-crystallin antibody were further probed with anti-Bcl-2, anti-Bak, antiBax, anti-Bcl-X S and anti-GFP antibodies ( Figure 5a ). As expected, anti-Bcl-2 and anti-Bak antibodies did not cross- GST pulldown assays to demonstrate that HaA and HaB can interact with Bax and Bcl-X S in vitro. The purified GST, GST-HaA and GST-HaB fusion proteins immobilized on glutathione-Sepharose beads were incubated with cell extracts from the HLE cells. After removal of nonspecific proteins by tris-buffered saline with tween-20 (TBS-T) washes, the associated proteins were eluted and separated by 10% SDS polyacrylamide gel electrophoresis (PAGE). The immunoblots were probed with the antibodies against different members of the Bcl-2 family as indicated in the figure. Only Bax and Bcl-X S were found bound to HaA and HaB. The lower panel shows equal input of GST, GST-HaA and GST-HaB react with any proteins precipitated down by anti-aA/Bcrystallin antibody (the top two panels of Figure 5a ). In contrast, both Bax and Bcl-X S were coimmunoprecipitated from pEGFP-HaA-HLE and pEGFP-HaB-HLE cells but not from pEGFP-HLE cells using anti-aA/B-crystallin antibody. HaB seemed to have slightly better affinity to Bax and Bcl-X S than HaA did (the middle two panels of Figure 5a ). Since these experiments were semiquantitative, such difference may not be significant. Analysis of Bax and Bcl-X S left in the supernatant fraction after immunoprecipitation revealed that more than 60% of total Bax and more than 80% of total Bcl-X S were precipitated down by the anti-aA/B-crystallin antibody (data not shown). Next, we performed the immunoprecipitations HaA[R116C] and HaB[R120G] showed much less protection on staurosporine-induced apoptosis and also displayed much weak interactions with Bcl-X S and Bax Two major mutants found in a-crystallin are R116C in HaA and R120G in HaB. Previous studies 73, 74 have shown that both mutants displayed decreased protection against apoptosis induced by staurosporine and other stress conditions. To explore the possible mechanisms for the decreased protection, we have created the two mutants using wild-type HaA and HaB cDNAs and PCR amplification procedure. The two mutants were fused into the GFP expression vector to generate pEGFP-HaA Staurosporine-induced mitochondrial translocations of Bax and Bcl-X S in pEGFP-HLE cells were blocked in pEGFP-HaA-HLE and pEGFPHaB-HLE cells
Bcl-2 family members are the major apoptotic regulators that control the homeostasis of mitochondria. Proapoptotic Bcl-2 family members such as Bax and Bcl-X S have been shown to be activated and translocated from the cytosol into mitochondria after apoptotic stimulation. 24, 38 Since human a-crystallins were able to interact with Bax and Bcl-X S in vitro and in vivo, we predicted that the translocation of Bax and Bcl-X S could be affected in the presence of HaA and HaB. To test this possibility, the pEGFP-HLE, pEGFP-HaA-HLE and pEGFPHaB-HLE cells were treated with either 0.01% DMSO or 100 nM staurosporine for 3 h and the mitochondrial-associated (M) and soluble (S) proteins were isolated from the three types of cells as described in Materials and Methods. Then, the same amounts of mitochondrial (M) and cytosolic proteins (S) were immunoblotted using the antibodies against superoxide dismutase (Mn 2 þ ), Bcl-2, Bcl-X L , Bak, Bax and Bcl-X S . The purity of mitochondrial fraction was shown by the exclusive distribution of a mitochondria-specific protein, superoxide dismutase (Mn 2 þ ) (Figure 8a ). Bcl-2, Bcl-X L and Bak were found to be associated with the mitochondrial membrane even after staurosporine treatment (Figure 8b-d) . The upregulated Bak found in pEGFP-HLE cells was also accumulated in the mitochondria (Figure 8d ). Bax was distributed in cytosol before staurosporine treatment in all (Figure 8e ). Bcl-X S was equally distributed in both the soluble fraction (S) and the mitochondria-associated fraction (M) before staurosporine treatment. After treatment with 100 nM staurosporine, more than 90% of Bcl-X S was translocated into mitochondria, leading to its dominant distribution in mitochondria and much less amount in the cytosolic fraction in pEGFP-HLE cells (top panel of Figure 8f ). In contrast, in pEGFP-HaA-HLE cells (middle panel of Figure 8f ) and pEGFP-HaB-HLE cells (bottom panel of Figure 8f ), the staurosporine-induced translocation of Bcl-X S was largely blocked as reflected by the even distribution of Bcl-X S in both cytosolic fraction and mitochondria with or without 100 nM staurosporine treatment. In contrast, the two prominent mutants, R116C and R120G, displayed much weaker abilities to sequester Bax (Figure 8g ) and Bcl-X S (Figure 8h ) in the cytosol. These results demonstrated that HaA and HaB can prevent the translocation of Bcl-X S and Bax into mitochondria after staurosporine stimulation.
HaA and HaB prevent staurosporine-induced cytochrome c release, caspase-3 activation and PARP cleavage
Earlier studies have shown that translocation of Bax directly induces release of cytochrome c from mitochondria and activation of caspase-3. [30] [31] As HaA and HaB can interact with Bax and Bcl-X S and prevent their translocation from the cytosol to mitochondria, we tested whether this sequestration could inhibit release of cytochrome c and suppress activation of caspase-3. Total proteins from both the cytosolic fraction and mitochondria of the three types of cells treated with 0.01% DMSO or 100 nM staurosporine for 0.5, 3 and 6 h were analyzed with Western blot analysis using an anti-cytochrome c antibody. As shown in Figure 9a , after 30-min treatment by staurosporine, no cytochrome c was released from either vector-or HaA-or HaB-transfected cells. As the treatment time increased to 3 h, staurosporine induced a substantial amount of cytochrome c released from mitochondria (M) into cytosol (S) in pEGFP-HLE cells (Figure 9b, top panel) . However, the release of cytochrome c was hardly observed in either HaA-or HaB-transfected HLE cells (Figure 9b , middle and bottom panels). By 6 h treatment, a majority of cytochrome c was released into cytoplasm in vector-transfected cells (Figure 9c, top panel) . In contrast, only a small amount of cytochrome c was released in HaA-and HaB-transfected HLE cells (Figure 9c , middle and bottom panels). Since differential release of cytochrome c was observed in the three types of cells, we predicted that activation of caspase-3 and downstream apoptotic events may also be different in these cells. To test this possibility, total proteins from these cells treated with either 0.01% DMSO or 100 nM staurosporine for 6 h were extracted for analysis of caspase-3 activity and cleavage of poly (ADP-ribose) polymerase (PARP), a substrate of caspase-3. As shown in Figure 10a , staurosporine treatment of pEGFP-HLE cells induced more than 17-fold activation of caspase-3 compared with DMSO treatment. In contrast, only two-to three-fold activation induced by staurosporine was observed in pEGFP-HaA-HLE and pEGFP-HaB-HLE cells in comparison with DMSO treatment. Consistent with differential caspase-3 activation, a large amount of PARP p116 was Figure 8 Demonstration that HaA and HaB prevent staurosporine-induced translocation of Bax and Bcl-X S from the cytosol into mitochondria (a-f) and that the two mutants, R116C in HaA and R120 in HaB, display much weaker ability to sequester the staurosporine-induced translocation of Bax and Bcl-X S from the cytosol into mitochondria (g-h). The pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells were grown to 100% confluence and then treated with 0.01% DMSO (DMSO) or 100 nM staurosporine (STS) for 3 h. These samples were then used for isolation of mitochondrial (M) and cytosolic (S) fractions. Total proteins were then extracted from the two fractions and subjected to Western blot analysis. Briefly, 50 mg of the mitochondrial protein (M) and cytosolic protein (S) from both control and treated cells were separated by 10% SDS-PAGE. The distributions of Mn-superoxide dismutase (marker for mitochondria-specific protein) (a), Bcl-2 (b), Bcl-X L (c), Bak (d), Bax (e) and Bcl-X S (f) were determined by Western blot analysis using the corresponding antibodies. Similarly, the pEGFP-HLE, pEGFP-HaA[R116C]-HLE and pEGFPHaB[R120G]-HLE cells were grown to 100% confluence and then treated with 0.01% DMSO (DMSO) or 100 nM staurosporine (STS) for 3 h. These samples were then used for isolation of mitochondrial (M) and cytosolic (S) fractions. Total proteins were then extracted from the two fractions and subjected to Western blot analysis using antibody against Bax (g) and Bcl-X S (h) as described above. Note that R116C and R120G display much weaker ability to sequester Bax (g) and Bcl-X S (h) in the cytosol compared with the sequestration of Bax (e) and Bcl-X S (f) by wild-type HaA and HaB a-Crystallin interacts with Bax and Bcl-X S Y-W Mao et al cleaved by caspase-3 to p85 in pEGFP-HLE cells after 6 h treatment by staurosporine. On the other hand, the degraded PARP (p85) was barely detectable in pEGFP-HaA-HLE and pEGFP-HaB-HLE cells (Figure 10b ). Thus, both HaA and HaB were able to block downstream apoptotic events through interactions with Bax and Bcl-X S .
HaA and HaB-crystallins display similar protection against apoptosis induced by different stress conditions in both lens and nonlens cells
Our results with HLE cells under treatment of 100 nM staurosporine suggest that HaA and HaB display similar protection against induced apoptosis. To further confirm these results, we introduced both HaA and HaB into a retina pigment epithelial cell line, ARPE-19, 75 and a rat embryonic myocardium cell line, H9c2. 76 Different from the SV40 large Ttransformed HLE cells that lack endogenous a-crystallin, both ARPE-19 and H9c2 express endogenous aB-crystallin. ARPE-19 cells expressed about 0.4 ng aB-crystallin/mg total proteins using purified aB-crystallin (Stressgen) as standard. The rat embryonic myocardium, H9c2 cells, expressed 0.21 ng aB-crystallin/mg total proteins, half of that found in ARPE-19 cells (data not shown). Accordingly, both ARPE-19 and H9c2 have much stronger resistance to staurosporineapoptosis in comparison with HLE cells in the absence of the exogenous a-crystallin expression (see the vector-transfected cells in Figure 11a , c and e). We suggest that different expression levels of the endogenous aB-crystallin levels likely contribute to their differential antiapoptotic abilities of ARPE-19 and H9c2 cells (see the vector-transfected cells in Figure  11c and e). Expression of the exogenous GFP-HaA or GFPHaB fusion protein in both ARPE-19 and H9c2 cells provides additional protection (Figure 11c-f) . When the established stable clones of vector or human a-crystallin-transfected ARPE and H9c2 cells (those clones expressing similar levels of GFP, GFP-HaA or GFP-HaB were used) were subjected to treatment of 100 nM staurosporine (Figure 11c and e), 10 mM etoposide (Figure 11d ) or 400 mM sorbitol (Figure 11f) , it was Figure 10 Demonstration that HaA and HaB prevent staurosporine-induced activation of caspase-3 and cleavage of PARP. (a) Caspase-3 activity in pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells after treatment with 0.01% DMSO (DMSO) or 100 nM staurosporine (STS). Caspase-3 activity was analyzed as described previously. 44, 45 Note that staurosporine induced more than 17-fold increase in caspase-3 activity compared to the DMSO control in vectortransfected cells. The activation of caspase-3 in HaA-and HaB-transfected cells was substantially repressed. (b) Western blot analysis of the caspase-3 substrate, PARP. Nuclear proteins (100 mg) from the pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells after treatment with 0.01% DMSO (control) or 100 nM staurosporine(STS) for 6 h were separated in an 8% SDS polyacrylamide gel. The PARP cleavage was detected with an anti-PARP antibody. Note that the p85 subunit was prominent in vector-transfected cells but barely detectable in HaA-and HaB-transfected cells after 100 nM staurosporine treatment Figure 9 Demonstration that HaA and HaB prevent staurosporine-induced release of cytochrome c. The pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells were grown to 100% confluence and then treated with 0.01% DMSO (control) or 100 nM staurosporine (STS) for 30 min (a), 3 h (b) and 6 h (c). These samples were then used for isolation of mitochondrial (M) and cytosolic (S) fractions. Total proteins were then extracted from the two fractions and subjected to Western blot analysis. Briefly, 50 mg of the mitochondrial fraction (M) and cytosolic fraction (S) from the control and treated cells were separated by 10% SDS-PAGE and the immunoblots were detected with an anti-cytochrome c antibody a-Crystallin interacts with Bax and Bcl-X S Y-W Mao et al found that both HaA and HaB displayed similar protection against all stress conditions tested ( Figure 11 ).
Discussion
In the present study, we have demonstrated the following: (1) both GST pulldown assay and coimmunoprecipitation demonstrate that HaA and HaB binds to Bax and Bcl-X S ; (2) the two prominent mutants, R116C in HaA and R120G in HaB, display much weaker affinity to Bax and Bcl-X S ; (3) the interactions between a-crystallin and Bax as well as Bcl-X S prevent their translocation into mitochondria during staurosporine-induced apoptosis; (4) the two prominent mutants, R116C and R120G, exhibit much attenuated sequestration of Bax and Bcl-X S in the cytosol; (5) both HaA and HaB display similar antiapoptotic ability as tested in three different cell lines under various stress conditions; (6) through inhibition of Bax and Bcl-X S translocation and repression of Bak upregulation, HaA and HaB prevent staurosporine-induced apoptosis. Thus, our results reveal a novel antiapoptotic mechanism for a-crystallin (Figure 12 ). ) and rat embryonic myocardium cells, H9c2 (e, f). After selection with G418 medium, stable clones expressing GFP, GFP-HaA or GFP-HaB were isolated. Their expression levels were determined by Western blot analysis. For all cells (HLE or ARPE-19 or H9c2), the clones with similar expression levels were used for analysis of the relative ability against induced apoptosis. Each stable clone was grown to 100% confluence and then subjected to treatment by 100 nM staurosporine (a, c, e), or 10 mM etoposide (b, d), or 400 mM sorbitol (f) for different length of time as indicated, the viability was then assayed as described in Figure 2a a-Crystallin interacts with Bax and Bcl-X S Y-W Mao et al
Antiapoptotic mechanisms of a-crystallins
The small heat-shock proteins have multiple functions. [39] [40] [41] [42] [43] [44] [45] [46] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] One of the most important functions is the ability to protect cell from induced apoptosis. [39] [40] [41] [42] [43] [44] [45] [46] a-Crystallin and Hsp27 are closely related family members and protect cells from apoptosis induced by a large numbers of stress factors. [39] [40] [41] [42] [43] [44] [45] [46] Both of them prevent stress-induced apoptosis at multiple signaling steps. However, the exact mechanism or regulating targets seem to be different. Hsp27 prevents apoptosis by interacting with caspase-3 to modulate its activity, [47] [48] by interacting with cytochrome c to prevent procaspase-9 activation, 49 or by regulating Bid intracellular distribution and F actin integrity to block mitochondrial death pathway. 52 In contrast, a-crystallin utilizes a different mechanism to negatively regulate caspase-3 activity. Our recent study shows that aB-crystallin prevents H 2 O 2 -induced apoptosis through interaction with procaspase-3 and partially processed procaspase-3 to prevent caspase-3 activation. 45 Secondly, instead of regulating Bid distribution, our results presented here demonstrate that a-crystallin binds to Bax and Bcl-X S to prevent their translocation into mitochondria induced by staurosporine, thus maintaining the integrity of mitochondria. The differential antiapoptotic mechanism was further illustrated in a recent study in which aB-crystallin but not Hsp27 was found capable of repressing differentiation-induced caspase-3 activation. 74 The results from both GST pulldown assay (Figure 4 ) and coimmunoprecipication-linked Western blot analysis with antibodies against aA/B-crystallin and Bcl-X S (Figure 5a and d) suggest that HaB seems to have slightly stronger affinity to Bax and Bcl-X S than HaA does. However, this is not consistent with the coimmunoprecipitation-linked Western blot analysis with anti-Bax antibody (Figure 5c ). Such discrepancy may be partially derived from the difference in the antibody affinity to the complexes precipitated and also partially resulted from variation from experiments to experiments (Figure 5c and Figure 7c ). Since both assays are semiquantitative, the observed differential affinity to Bax and Bcl-X S displayed by HaA and HaB need to be further explored. Nevertheless, our observation that both HaA and HaB bind to these proapoptotic regulators and sequester their translocation into mitochondria during staurosporine-induced apoptosis is important for understanding the antiapoptotic mechanisms of HaA and HaB.
The two major mutants, R116C in HaA and R120G in HaB, cause cataractogenesis in the lens. 77, 78 Consistent with these observations, the chaperone-like ability of R116C and R120G was found substantially decreased. 79, 80 The results reported here and also from earlier studies [73] [74] reveal that the two mutants apparently display much weaker antiapoptotic ability. Our demonstration that the mutants have much less affinity to Bax and Bcl-X S provides an explanation. Part of their attenuated antiapoptotic ability is derived from their weak interactions with Bax and Bcl-X S and thus decreased ability to sequester translocation of Bax and Bcl-X S from cytosol into mitochondria induced by staurosporine treatment. Why R116C and R120G display deceased affinities to Bax and Bcl-X S remains to be further studied.
An early study 43 has suggested that aA-crystallin is more competent than aB-crystallin in preventing apoptosis induced by staurosporine, TNF-a and UVA. In the present study, we have compared the antiapoptotic ability of the two crystallins in three different cell lines: the human lens epithelial cell line (HLE) which contains virtually undetectable endogenous crystallins; the human retina pigment epithelial cells (ARPE-19) and the rat embryonic myocardium cell line (H9c2), both of which expresses endogenous aB-crystallin. The expression of the endogenous aB-crystallin in ARPE-19 and H9c2 cells makes them much more resistant to staurosporine-induced apoptosis in the absence of exogenous a-crystallin expression ( Figure 11) . Regardless absence or presence of the endogenous a-crystallin, expression of HaA and HaB in these cells provides additional protections. Under treatment of 100 nM staurosporine, 10 mM etoposide or 400 mM sorbitol (generating osmotic stress), HaA and HaB consistently show similar protections against a given stress condition in HLE, ARPE-19 or H9c2 cells.
Signaling pathway mediating staurosporineinduced apoptosis
Apoptosis occurs through two major signaling pathways: extrinsic or intrinsic. 81 The extrinsic pathway initiated from activation of death domain containing cell surface receptors of the tumor necrosis factor (TNF) super family leads to the recruitment and proteolytic activation of caspase-8, which results in the cleavage and activation of downstream effector caspases. [82] [83] The intrinsic apoptotic signaling pathway involves mitochondria and results in the release of proapoptotic factors from mitochondria, such as cytochrome c. The released cytochrome c binds to the apoptotic protease- Figure 12 Diagram to show the apoptotic pathway for staurosporine-induced apoptosis in HLE cells and the protective mechanisms of HaA and HaB against staurosporine-induced apoptosis. Staurosporine induces upregulation of Bak and translocation of Bax and Bcl-X S , leading to alteration in the permeability of mitochondria as reflected by release of cytochrome c, which causes activation of caspase-3 and cleavage of PARP, and eventually execution of the apoptotic program. HaA and HaB block upregulation of Bak and translocation of Bax and Bcl-X S , and consequently suppress downstream apoptotic events activating factor-1(Apaf-1), subsequently turns on the downstream executioner caspases such as caspase-3. [84] [85] [86] Staurosporine, a potent apoptosis inducer demonstrated in a broad spectrum of cells activate apoptosis through the mitochondrial death pathway. [87] [88] [89] [90] [91] The proapoptotic members of the Bcl-2 family play a critical role in staurosporineinduced apoptosis. Cells lacking both Bax and Bak are known to be completely resistant to multiple apoptotic stimuli including staurosporine. [92] [93] Analysis of cell death in Bax-or Bak-deficient cell lines indicates that both regulators are necessary for staurosporine-induced apoptosis. 94, 95 Consistent with these studies, here we show that in HLE cells staurosporine regulates both Bak and Bax at different ways.
Staurosporine was found to upregulate Bak expression up to five-fold (Figure 3 ) and the upregulated Bak was accumulated into mitochondria (Figure 8 ) in vector-transfected cells. In the HaA-and HaB-transfected cells, Bak upregulation is different. First, expression of HaA and HaB enhances Bak expression in unknown mechanism. On the other hand, expression of HaA-and HaB prevents staurosporine-induced additional Bak upregulation (Figure 3 ). Since cells lacking both Bax and Bak are completely resistant to staurosporine, 92, 93 inhibition of additional Bak upregulation by HaA-and HaB, to some degree, contributes to their antiapoptotic abilities against staurosporine-induced apoptosis. Bak upregulation is also observed in human colonic adenoma AA/C1 cells during butyrate-induced apoptosis, 96 and in human stomach epithelial cells during bacterium-induced apoptosis. 97 It is well established that death signal induced conformation change followed by insertion into mitochondrial membrane is an important step for Bax to promote apoptosis. [25] [26] [27] [28] Although staurosporine does not induce Bax upregulation, this kinase inhibitor promotes Bax translocation from cytosol into mitochondria in vector-transfected cells, thus turning on the mitochondrial death pathway. This process is largely abrogated in cells expressing either HaA or HaB (Figure 8e ).
In addition, our results demonstrate that staurosporine also regulates Bcl-X S . It also stimulates translocation of Bcl-X S from cytosol into mitochondria in vector-transfected pEGFP-HLE cells. To our knowledge, this is the first evidence that Bcl-X S translocation is stimulated by staurosporine. Again, HaA and HaB prevent translocation of Bcl-X S (Figure 8f) .
In vector-transfected cells, once the proapoptotic members, Bax and Bcl-X S , were mobilized into mitochondria, the integrity of mitochondria was interrupted as evidenced by the release of cytochrome c, followed by activation of executioner caspase, caspase-3 and degradation of PARP. These downstream events induced by staurosporine in vector-transfected HLE cells are similar to those reported in other cell lines. [87] [88] [89] [90] [91] In either HaA-or HaB-transfected cells, the staurosporine-induced downstream events were largely turned off. Thus, our results provide additional evidence that both Bax and Bak are important for staurosporine-induced apoptosis. Moreover, our demonstration that staurosporine stimulates translocation of Bcl-X S provides novel information for our understanding of staurosporine-induced signaling pathway (Figure 12 ). Culture of HLE, human retina pigment epithelial cells (ARPE-19) and rat embryonic myocardium cells (H9c2)
Materials and Methods
Chemicals
The HLE cells, kindly provided by Dr. V Reddy, were grown in Dulbecco's modified Eagle's medium (Gibco catalog number 31600-026) containing 10% fetal bovine serum as described previously. 98 The medium was prepared in ion-exchanged double-distilled water to give an osmolarity of 30075 mosmol supplemented with 26 mM NaHCO 3 and 50 U/ml penicillin and streptomycin. The media and sera were sterilized by filtration through 0.22-mm filters (Corning catalog number 25942) with pH adjusted to 7.2. All cells were kept at 371C and 5% CO 2 gas phase. The human retina pigment epithelial cells (ARPE-19) 75 and rat embryonic myocardium cells (H9c2) 76 were obtained from ATCC and grown in Eagle's minimal essential medium (MEM) (Fisher Scientific) with addition of 10% fetal bovine serum and 50 U/ml penicillin and streptomycin.
Preparation of expression constructs
The HaA and HaB cDNAs were amplified by RT-PCR from human lens mRNA using the following primers:
0 (aB-crystallin, reverse). The cDNAs were further inserted into an enhanced green fluorescence protein expression vector, pEGFPC3, at the XhoI and SmaI sites that were created by PCR to generate in frame fusion constructs. The pGST-HaA/B-crystallin fusion constructs were created by PCR using the following primers:
0 -CAAGTCGACTTCAAGAAAGGGCATCTA-3 0 (aB-crystallin, reverse). The amplified HaA and HaB cDNAs were subcloned into pGEX-4T-1 (Pharmacia Biotech), fused in frame with GST at the EcoRI and SalI sites. pEGFP-HaA-Del and pEGFP-HaB-Del were generated using PCR and the following primers: In vitro mutagenesis for creation of R116C and R120G mutants
The two prominent mutants R116C and R120G were created through a two-step PCR amplification procedures with the following primers:
0 (R120G, reverse-2). For R116C generation, wild-type HaA was used as the template in the initial two PCR reactions. One PCR reaction was conducted with the R116C Nterminal primer pair (forward-1 and reverse-1), and the other conducted with R116 C-terminal primer pair (forward-2 and reverse-2). The products from the two PCR reactions were gel-purified to remove the initial template (HaA full-length cDNA). The recovered two partial cDNAs carrying the mutated codon (from Arg-116 to Cys-116) were first denatured and then annealed together, and the ends are filled with klenow DNA polymerase. The newly annealed mutated cDNA was used for template in the third PCR reaction in which the R116C forward-1 primer, 5
0 -TACCTCGAGATG-GACGTGACCATCCAGC-3 
Establishment of stable expression cell lines
The pEGFP, pEGFP-HaA and pEGFP-HaB constructs were amplified in DH-5a and purified by two rounds of CsCl ultracentrifugation as previously described. 44, 45 Transfection of HLE, ARPE-19 and H9c2 cells was performed using electroporation with a BTX Electro Cell Manipulator as described before 44, 45 or with Lipofectaminet 2000 from the Invitrogen Life Technologies, according to the company instruction manual. The transfected cells were then subjected to G418 (400-600 mg/ml) selection for 4-6 weeks and then the individual clones for the following stable transfected cell lines were established. These include pEGFP-HLE, pEGFP-ARPE-19 and pEGFP-H9c2 (expressing only the GFP from the vector); pEGFP-HaA-HLE, pEGFP-HaA-ARPE-19 and pEGFP-HaA-H9c2 fetal calf serum in the presence of 400-600 mg/ml G418. Then, the media containing 10% serum plus 0.01% DMSO (control) or 100 nM staurosporine, 10 mM etoposide or 400 mM sorbitol (experiment) were used to replace the culture media for the required period of incubation as indicated. After treatment, all samples were collected for analysis of apoptosis, apoptotic pathways and protein-protein interactions.
Apoptosis assay, DNA fragmentation analysis and Hoechst staining
The percentage of apoptotic cells in DMSO or staurosporine, etoposide or sorbitol-treated samples was determined as described before. 99 The apoptotic nature of the treated cells was further verified by DNA fragmentation and Hoechst staining as previously described. 4, 44, 45, 99 Protein preparation and Western blotting analysis
The total proteins were prepared from the pEGFP-HLE, pEGFP-HaA-HLE, pEGFP-HaB-HLE, pEGFP-HaA[R116C]-HLE, pEGFPHaB[R120G]-HLE, pEGFP-HaA-Del-HLE and pEGFP-HaB-Del-HLE cells treated with 0.01% DMSO or 100 nM staurosporine for 30 min-6 h using protein extraction buffer. The buffer contained 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 9.1 mM Na 2 HPO 4 , 1.7 mM NaH 2 PO 4 , 150 mM NaCl, 10 ml/ml phenylmethylsufonyl fluoride (PMSF) stock solution (10 mg/ ml in isopropanol), 30 ml/ml aprotinin with pH of the preparation adjusted to 7.4. After homogenization by passing through a 21-gauge needle, an additional 10 ml of PMSF was added to each sample, which was incubated on ice for 30 min. After the cell lysate was centrifuged at 10 000 Â g for 20 min at 41C, the supernatant fraction of each sample was collected and stored in aliquots at À701C. For each sample, the protein concentration was determined as previously described. 44, 45 In total, 50 or 100 mg of total proteins in each sample were resolved by 10% SDS-polyacrylamide gel and transferred into supported nitrocellulose membranes. The protein blots were blocked with 5% nonfat milk in tris-buffered saline (TBS) (10 mM Tris HCl, pH 8.0/150 mM NaCl) overnight at 41C, and incubated with anti-aA/B-crystallin antibody (StressGen Biotechnologies), anti-bactin, anti-Bax, anti-Bcl-X S/L , anti-Bcl-2 and anti-cytochrome c antibodies (Santa Cruz Biotechnology), anti-Bak antibody (Upstate Biotechnology), anti-PARP antibody and anti-GFP antibody (Roche Molecular Biochemicals) at a dilution of 1:500-2000 (mg/ml) in 5% milk prepared in TBS. The secondary antibody is anti-mouse IgG (for anti-GFP and anti-Bcl-2 antibodies), anti-rabbit IgG (for anti-aA/B-crystallin, anti-Bax, anti-Bcl-X S/L , anti-cytochrome c and anti-Bak antibodies), or anti-goat IgG (for anti-actin) at a dilution of 1:1000 (Amersham). Immunoreactivity was detected with an enhanced chemilluminescence detection kit according to the company's instruction (ECL, Amersham Corp.).
GST pulldown assay
Human aA-and aB-crystallin cDNAs were subcloned into vector pGEX-4T-1. Both vector and expression constructs were transfected into E.coli BL21. When E.coli BL21 was grown to OD 600 ¼ 0.5 at 371C, IPTG was added into the medium to a final concentration of 0.5 mM. The culture was continued overnight at 201C. Thereafter, cells were harvested by centrifugation, frozen and thawed twice by immersing the tubes in dry ice and a 371C water bath, and resuspended in 1/50 of the starting culture volume of phosphate-buffered saline (PBS), pH 7.2, 5 mM EDTA, 1 mM dithiothreitol (DTT), 2 mg/ml aprotinin, 2 mM phenylmethylsulfonyl fluoride (PMSF) and 2 mg/ml lysozyme. After 30 min on ice, Triton X-100 was added to a final concentration of 1% and the cells were sonicated. The supernatant fraction was collected by centrifugation and incubated with the glutathione-Sepharose beads (Sigma) for 1 h. The beads were washed with 1 Â PBS, 1% Triton X-100, 5 mM EDTA, 1 mM DTT, 2 mg/ml aprotinin and 1 mM PMSF four times. GST alone, GST-HaA or GST-HaB fusion proteins immobilized on glutathione-agarose beads were incubated with HLE cell lysate overnight at 41C. The nonspecific binding proteins were washed off the beads with TBST buffer (20 mM Tris-Cl, pH 7.4; 150 mM NaCl; 2 mM EDTA; 1% Triton X-100) four times. The interacting proteins were further analyzed by Western blot using anti-Bax and anti Bcl-X S antibodies.
Immunoprecipitation-linked Western blot analysis
The pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE, pEGFPHaA[R116C]-HLE, pEGFP-HaB[R120G]-HLE, pEGFP-HaA-Del-HLE and pEGFP-HaB-Del-HLE cells were grown to 100% confluence and treated with 0.01%. DMSO or 100 nM staurosporine for 3 h as described above. The treated cells were harvested by the end of treatment and used for extraction of total proteins. The protein samples were quantitated and processed for immunoprecipitation-linked Western blot analysis as described below. First, 500 mg of total proteins from pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE, pEGFP-HaA[R116C]-HLE, pEGFP-HaB[R120G]-HLE, pEGFP-HaA-Del-HLE and pEGFP-HaBDel-HLE cells were incubated with 10 mg of antibody against aA/Bcrystallins, Bax, Bcl-X S , Bcl-2 or Bak as well as 50 ml protease inhibitor cocktail for 1 h on ice. After incubation, 50 ml of protein A/G plus agarose were added into each incubated sample. These samples were then incubated overnight in a 41C refrigerator attached to a slow motion rotator. At the end of incubation, these samples were washed three times with RIPA buffer (1 Â PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) by spinning down for 5 min at 10 000 Â g. After final wash, the pelleted samples were subjected to Western blot analysis as described above using proper antibodies indicated in the text.
Preparation of mitochondrial and soluble proteins
Preparation of mitochondrial and cytosolic proteins was conducted as described previously. 100 Briefly, 40 dishes (100 mm) of pEGFP-HLE, pEGFP-HaA-HLE and pEGFP-HaB-HLE cells in 100% confluence were treated with 0.01% DMSO or 100 nM staurosporine for 3 h. The cells were harvested and washed twice with PBS. The cell pellets were resuspended in hypotonic buffer (10 mM NaCl, 1.5 mM MgCl 2 , 10 mM HEPES, pH 7.5) with protease inhibitors and incubated on ice for 30 min. Then the cells were lysed with homogenizers for 20 strokes, and the 4 Â MS buffer was added into cell lyses to obtain a final concentration of 1 Â MS buffer (110 mM mannitol, 280 mM sucrose, 40 mM HEPES, pH 7.5, 1 mM EDTA, 0.05% BSA, plus protease inhibitors). The cell lysates were centrifuged at 1000 Â g for 5 min at 41C to remove nuclei and unbroken cells. The supernatant was further centrifuged at 17 000 Â g at 41C for 20 min to separate mitochondrial/heavy membrane fraction and soluble fraction. The mitochodrial/heavy membrane fraction was lysed in protein extraction buffer as described above. The protein concentrations in both fractions were determined as described above. Equal amounts of protein in the mitochondrial/heavy membrane fraction and soluble fraction were separated in 10% SDS-PAGE and assayed by different antibodies as described above. The nuclear proteins were further analyzed with anti-PARP antibody (Pharmingen) to detect PARP cleavage during staurosporine-induced apoptosis.
